Cargando…

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years

IMPORTANCE: This work quantifies the fatal burden of dementia associated with Alzheimer disease in individuals with Down syndrome (DS). OBJECTIVE: To explore the association of dementia associated with Alzheimer disease with mortality and examine factors associated with dementia in adults with DS. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hithersay, Rosalyn, Startin, Carla M., Hamburg, Sarah, Mok, Kin Y., Hardy, John, Fisher, Elizabeth M. C., Tybulewicz, Victor L. J., Nizetic, Dean, Strydom, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439956/ https://www.ncbi.nlm.nih.gov/pubmed/30452522 http://dx.doi.org/10.1001/jamaneurol.2018.3616

Ejemplares similares

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome
por: D’Souza, Hana, et al.
Publicado: (2020)

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome
por: Firth, Nicholas C., et al.
Publicado: (2018)

The importance of understanding individual differences in Down syndrome
por: Karmiloff-Smith, Annette, et al.
Publicado: (2016)

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer’s Disease in Down Syndrome
por: Pape, Sarah E., et al.
Publicado: (2021)

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2016)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
por: Startin, Carla M., et al.
Publicado: (2019)

Health comorbidities and cognitive abilities across the lifespan in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2020)

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls
por: Hamburg, Sarah, et al.
Publicado: (2021)

Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)
por: Startin, Carla M., et al.
Publicado: (2016)

Intracerebral haemorrhage in Down syndrome: protected or predisposed?
por: Buss, Lewis, et al.
Publicado: (2016)

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome
por: Hamburg, Sarah, et al.
Publicado: (2019)

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome
por: Saini, Fedal, et al.
Publicado: (2023)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

Erratum to “Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome” [Neurobiol. Aging 35 (2014) 1513.e1–1513.e5]
por: Mok, Kin Y., et al.
Publicado: (2014)

Erratum to “Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome” [Neurobiol. Aging 35 (2014) 1513.e1–1513.e5]
por: Mok, Kin Y., et al.
Publicado: (2014)

Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APP
por: Nizetic, Dean, et al.
Publicado: (2015)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2020)

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2021)

Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta‐analyses
por: Alhajraf, Falah, et al.
Publicado: (2019)

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome()
por: Mok, Kin Y., et al.
Publicado: (2014)

Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB)
por: Sinai, Amanda, et al.
Publicado: (2016)

Down syndrome: searching for the genetic culprits
por: Lana-Elola, Eva, et al.
Publicado: (2011)

Down syndrome—recent progress and future prospects
por: Wiseman, Frances K., et al.
Publicado: (2009)

Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome
por: Jones, Emma L., et al.
Publicado: (2013)

Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome
por: De Vita, S, et al.
Publicado: (2010)

The Embryonic mir-35 Family of microRNAs Promotes Multiple Aspects of Fecundity in Caenorhabditis elegans
por: McJunkin, Katherine, et al.
Publicado: (2014)

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy
por: Lyons, Laura, et al.
Publicado: (2010)

Comparison of Sleeve Gastrectomy vs Intensive Lifestyle Modification in Patients With a BMI of 30 to Less Than 35
por: Stenberg, Erik, et al.
Publicado: (2022)

An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model
por: Mensah, Afua, et al.
Publicado: (2007)

Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21
por: Ruparelia, Aarti, et al.
Publicado: (2010)

Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models
por: Dekker, Alain D., et al.
Publicado: (2017)

Drosophila Protamine-Like Mst35Ba and Mst35Bb Are Required for Proper Sperm Nuclear Morphology but Are Dispensable for Male Fertility
por: Tirmarche, Samantha, et al.
Publicado: (2014)

Rodent models in Down syndrome research: impact and future opportunities
por: Herault, Yann, et al.
Publicado: (2017)

Structural Connectivity in Down Syndrome and Alzheimer’s Disease
por: Saini, Fedal, et al.
Publicado: (2022)

Association of Dual Decline in Memory and Gait Speed With Risk for Dementia Among Adults Older Than 60 Years: A Multicohort Individual-Level Meta-analysis
por: Tian, Qu, et al.
Publicado: (2020)

Association of Focused Medication Review With Optimization of Psychotropic Drug Prescribing: A Systematic Review and Meta-analysis
por: Sheehan, Rory, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_83slbpmsctagq8s0qgpo6gus8i